InKeiji AIbyJimeng·Mar 17One Shot at Approval: How the FDA’s Single-Trial Shift Changes Clinical DevelopmentThe FDA made it official in February 2026: one well-controlled pivotal trial, paired with confirmatory evidence, is now the default pathway…
Jimeng·Feb 17When Cursor silently raised their price by over 20× and more, what is the message the users are…Cursor’s pricing controversy is best understood as a shift from request-based SaaS packaging (“500 fast premium requests + unlimited slow…
InKeiji AIbyJimeng·Jan 29Don’t Delegate, Do It Yourself — The New Way to Work in the Age of AIFor fifty years, the best career advice was simple: learn to delegate. As you rise, stop doing and start managing. Your job is to set…
InKeiji AIbyJimeng·Jan 15The AI Regulation Revolution: How New FDA and EMA Guidance Opens the Clinical Trials MarketJimeng Sun and TrialMind
InKeiji AIbyJimeng·Nov 17, 2025Understanding AI’s New Power Duo: MCP and Claude SkillsJimeng Sun, Keiji AI | UIUC
InKeiji AIbyJimeng·Nov 13, 2025Predicting Clinical Trial Success: From Machine Learning to Agentic AI and BeyondNovember 5, 2025 · Zifeng Wang, PhD, Keiji AI
Jimeng·Nov 5, 2025Developing Generative AI for Clinical Trial Recruitment: From Patient to TrialsBy Zifeng Wang, PhD, Keiji AI
InKeiji AIbyJimeng·Jun 21, 2025Powering the Next Generation of Clinical Research: How MCP Unleashes TrialMind AgentsWith pharmaceutical companies spending over $50 billion annually on clinical development while facing 90% failure rates, the strategic…
Jimeng·May 17, 2025Being a Computer Science Professor: The Ultimate Career in the Age of AIIn the fast-paced world of technology, where industry giants offer eye-popping salaries and glamorous perks, choosing academia might seem…
InKeiji AIbyJimeng·Mar 12, 2025Clinical Trials Demystified: An AI Researcher’s Guide (Part 2)Clinical Trial Software & Vendors